Cancer-specific survival | 7 years (%) | 95% CI | p value | |
---|---|---|---|---|
All patients | RP | 98.1 | 0.968-0.989 | <0.001 |
IMRT | 92.1 | 0.858-0.957 | ||
Low risk | RP | 99.3 | 0.951-0.999 | 0.089 |
IMRT | 97.4 | 0.825-0.996 | ||
Intermediate risk | RP | 99.6 | 0.983-0.999 | 0.003 |
IMRT | 94.1 | 0.823-0.981 | ||
High risk | RP | 93.0 | 0.878-0.960 | 0.07 |
IMRT | 85.4 | 0.704-0.932 |